Lyme disease
- PMID: 8312152
Lyme disease
Abstract
Years before the spirochetal etiology of Lyme disease was determined, the effectiveness of antibiotic treatment for erythema chronicum migrans had been established. Revisions in antibiotic treatment have evolved in concert with a growing understanding of the pathogenesis of Lyme disease. Current treatment recommendations are discussed.
Similar articles
-
Antimicrobial susceptibility of Borrelia burgdorferi sensu lato: what we know, what we don't know, and what we need to know.Wien Klin Wochenschr. 2006 Nov;118(21-22):659-68. doi: 10.1007/s00508-006-0693-z. Wien Klin Wochenschr. 2006. PMID: 17160604 Review.
-
[Treatment of Borrelia burgdorferi infection].Enferm Infecc Microbiol Clin. 1991 Jan;9(1):52-4. Enferm Infecc Microbiol Clin. 1991. PMID: 2029560 Review. Spanish. No abstract available.
-
[Erythema chronicum migrans].Rev Prat. 2013 Feb;63(2):178. Rev Prat. 2013. PMID: 23513773 French. No abstract available.
-
Comparison of cefuroxime axetil and doxycycline in treatment of patients with early Lyme disease associated with erythema migrans.Antimicrob Agents Chemother. 1995 Mar;39(3):661-7. doi: 10.1128/AAC.39.3.661. Antimicrob Agents Chemother. 1995. PMID: 7793869 Free PMC article. Clinical Trial.
-
Lyme disease.Dermatol Clin. 1992 Oct;10(4):763-75. Dermatol Clin. 1992. PMID: 1395157 Review.
Cited by
-
Clarithromycin in treatment of early Lyme disease: a pilot study.Antimicrob Agents Chemother. 1996 Feb;40(2):468-9. doi: 10.1128/AAC.40.2.468. Antimicrob Agents Chemother. 1996. PMID: 8834900 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical